Inici › Càncer de pròstata › Florida › Orlando
Assaigs clínics de Càncer de pròstata a Orlando, FL
17 estudis de Càncer de pròstata busquen participants en centres de Orlando i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutantFase 1/2
- Advent Health, Orlando
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
ReclutantFase 2
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · a 16 mi
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
ReclutantFase 2/3
- AdventHealth, Orlando
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
ReclutantFase 3
- AdventHealth, Orlando
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
ReclutantFase 2
- Orlando VA Medical Center, Orlando, FL, Orlando
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
ReclutantFase 2
- Orlando VA Medical Center, Orlando, FL, Orlando
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Reclutant
- AdventHealth, Orlando
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
ReclutantFase 1/2
- Research Site, Orlando
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
ReclutantFase 1
- Sarah Cannon Research Institute @ Florida Cancer, Orlando
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
ReclutantFase 1/2
- Research Site, Orlando
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
ReclutantFase 1
- AdventHealth Orlando, Orlando
A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors
ReclutantFase 1
- Florida Cancer Specialists & Research Institute, Orlando
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
ReclutantFase 1/2
- Research Site 137, Orlando
- Research Site 118, Celebration · a 17 mi
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Adventhealth, Orlando
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
ReclutantFase 1
- Exelixis Clinical Site #8, Orlando
Exploring the Potential of Robotic Telesurgery in Remote Settings
Reclutant
- AdventHealth, Celebration · a 17 mi
PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
ReclutantFase 2
- AdventHealth, Orlando
Assaigs de Càncer de pròstata en altres ciutats
- New York City, NY103 estudis
- Houston, TX76 estudis
- Los Angeles, CA61 estudis
- Boston, MA59 estudis
- St. Louis, MO46 estudis
- Chicago, IL45 estudis
- San Francisco, CA45 estudis
- Philadelphia, PA44 estudis
- Baltimore, MD43 estudis
- Nashville, TN42 estudis
- Seattle, WA42 estudis
- Washington, DC38 estudis
Altres estudis a Orlando
- Càncer de pulmó de cèl·lules no petites44 estudis
- Obesitat31 estudis
- Càncer metastàtic29 estudis
- Sobrepès27 estudis
- Malaltia d'Alzheimer25 estudis
- Diabetis tipus 224 estudis
- Càncer (tots els tipus)24 estudis
- Càncer de mama23 estudis
- Càncer d'ovari22 estudis
- Colitis ulcerosa22 estudis
- Càncer de pulmó21 estudis
- Càncer colorrectal19 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.